Enzymotec Overview
- Year Founded
-
1998

- Status
-
Acquired/Merged
- Employees
-
235

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$290M
Enzymotec General Information
Description
Producer and seller of lipid-based bioactive ingredients created to offer medical foods based on sophisticated processes and technologies. The company's lipid-based bioactive ingredients are used in a wide range of products, including a drugs for reducing cholesterol and the treatment of attention disorders and slowing cognitive degeneration in adults, as well as nutritional supplements, enabling the nutritional supplement, healthcare, medical foods and infant formula industries avail advanced products in order to produce infant food and nutritional supplements.
Contact Information
Website
www.enzymotec.comCorporate Office
- P.O. Box 6
- Migdal Haemek 2310001
- Israel
Corporate Office
- P.O. Box 6
- Migdal Haemek 2310001
- Israel
Enzymotec Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Merger/Acquisition | 20-Dec-2017 | $290M | Completed | Profitable | ||
8. Secondary Transaction - Open Market | 24-Aug-2017 | Completed | Profitable | |||
7. Secondary Transaction - Open Market | 09-Feb-2016 | Completed | Profitable | |||
6. Secondary Transaction - Open Market | 05-Mar-2014 | Completed | Profitable | |||
5. IPO | 27-Sep-2013 | Completed | Profitable | |||
4. PE Growth/Expansion | Completed | Generating Revenue | ||||
3. Early Stage VC (Series B1) | 02-Feb-2009 | Completed | Generating Revenue | |||
2. Early Stage VC | 20-Jun-2001 | $2M | $3M | Completed | Product Development | |
1. Early Stage VC | 01-Jan-2000 | $1M | $1M | Completed | Product Development |
Enzymotec Comparisons
Industry
Financing
Details
Enzymotec Competitors (1)
One of Enzymotec’s competitors is Rochem International, a Corporation company based in Hauppauge, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Rochem International | Corporation | Hauppauge, NY |
Enzymotec Patents
Enzymotec Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190327997-A1 | Oil blends and processes for their preparation | Inactive | 17-Aug-2016 | ||
JP-2019524141-A | Oil blends and methods of preparing them | Active | 17-Aug-2016 | ||
US-20180139998-A1 | Lipid compositions for improving sleep | Inactive | 04-May-2015 | ||
US-20180228819-A1 | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation | Inactive | 21-Apr-2015 | ||
EP-3285602-A1 | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation | Inactive | 21-Apr-2015 | A61K31/661 |
Enzymotec Signals
Enzymotec Former Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Arancia | Corporation | Minority | ||
Galam | PE-Backed Company | Minority | ||
GlenRock Israel | Growth/Expansion | Minority | ||
Israel Secondary Fund | Secondary Buyer | Minority | ||
Millennium Materials Technologies Fund | Venture Capital | Minority |
Enzymotec Investments (2)
Enzymotec’s most recent deal was a Corporate Asset Purchase with Enzymotec (Rights to Five Nutritional Products). The deal was made on 30-Aug-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Enzymotec (Rights to Five Nutritional Products) | 30-Aug-2017 | Corporate Asset Purchase | Buildings and Property | ||
Advanced Lipids | 26-Jun-2007 | Joint Venture | Food Products |
Enzymotec FAQs
-
When was Enzymotec founded?
Enzymotec was founded in 1998.
-
Where is Enzymotec headquartered?
Enzymotec is headquartered in Migdal Haemek, Israel.
-
What is the size of Enzymotec?
Enzymotec has 235 total employees.
-
What industry is Enzymotec in?
Enzymotec’s primary industry is Other Consumer Non-Durables.
-
Is Enzymotec a private or public company?
Enzymotec is a Private company.
-
What is the current valuation of Enzymotec?
The current valuation of Enzymotec is
. -
What is Enzymotec’s current revenue?
The current revenue for Enzymotec is
. -
How much funding has Enzymotec raised over time?
Enzymotec has raised $76M.
-
Who are Enzymotec’s investors?
Arancia, Galam, GlenRock Israel, Israel Secondary Fund, and Millennium Materials Technologies Fund are 5 of 9 investors who have invested in Enzymotec.
-
Who are Enzymotec’s competitors?
Rochem International is a competitor of Enzymotec.
-
When was Enzymotec acquired?
Enzymotec was acquired on 20-Dec-2017.
-
Who acquired Enzymotec?
Enzymotec was acquired by NovaTaste Austria.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »